Novotech, which has had a bumper year despite the economic downturn, according to chief executive Alek Safarian, will begin recruiting clinical research associates shortly.

Safarian told BTN the global economic downturn had reinforced the company’s view that its future would be in providing clinical trials services in Asia.

“Most of the [client] companies we work with are based in the US and Europe, and one of the things we’ve learned over the last year as a result of the credit crunch is that the pace of expansion of clinical trials in this part of the world has accelerated,” he said.

“So we think as the world comes out of recession that will stay and the need for clinical trial services across the region will keep growing.”

By Nick Evans

http://biotechnologynews.net/